Interim report Q2/2024: Enzymatica builds momentum for expansion
Second quarter January-June · Net sales · Net sales reached SEK 15.8 (21.8)reached SEK 6.4 million.(8.8) · The operating result totaled SEK -31.9 (million. -25.5) million. · The operating · Earnings per share, basic and diluted,result totaled SEK were SEK -0.19 (-0.16).-13.5 (-11.2) · Cash flow from operating activities formillion. the period totaled SEK -26.3 (-21.7) · Earnings per million.share, basic anddiluted, were SEK-0.08 (-0.07). · Cash flow fromoperatingactivities totaledSEK